Federal Register / Vol. 66, No. 102 / Friday, May 25, 2001 / Notices 28919

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Dental &

Craniofacial Research; Notice of

Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Dental and Craniofacial Research Special

Emphasis Panel, 01–63, Review of K08

Grants.

Date: May 21, 2001.

Time: 11 am to 1 pm.

Agenda: To review and evaluate grant

applications.

Place: 45 Center Drive, Natcher Building,

Conference Room C, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Yujing Liu, MD, PhD,

Scientific Review Administrator, National

Institute of Dental & Craniofacial Res., 45

Center Drive, Natcher Building, Rm. 4AN44F,

Bethesda, MD 20892, (301) 594–2372.

This notice is being published less than 15

days prior to the meeting due to the timing

limitations imposed by the review and

funding cycle.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.121, Oral Diseases and

Disorders Research, National Institutes of

Health, HHS)

Dated: May 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13197 Filed 5–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel.

Date: June 14, 2001.

Time: 1 pm to 5 pm.

Agenda: To review and evaluate contract

proposals.

Place: 6700–B Rockledge Drive, Room

2103, Bethesda, MD 20892 (Telephone

Conference Call).

Contact Person: Anna L. Ramsey-Ewing,

Scientific Review Administrator, Scientific

Review Program, Division of Extramural

Activities, NIAID, NIH, Room 2220, 6700–B

Rockledge Drive, MSC 7610, Bethesda, MD

20892–7610, 301–496–2550.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.855, Allergy, Immunology,

and Transplantation Research; 93.856;

Microbiology and Infectious Diseases

Research, National Institutes of Health, HHS)

Dated: May 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13198 Filed 5–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Diabetes and

Digestive and Kidney Diseases; Notice

of Closed Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The grant applications and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the grant

applications, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Diabetes and Digestive and Kidney Diseases

Special Emphasis Panel, ZDK1 GRB 5 O2.

Date: June 6, 2001.

Time: 2 pm to 3 pm.

Agenda: To review and evaluate grant

applications.

Place: 6707 Democracy Blvd, 2 Democracy

Plaza, Rm 653, Bethesda, MD 20892

(Telephone Conference Call).

Contact Person: Francisco O. Calvo, Chief,

Review Branch, DES NIDDK, Room 752, 6707

Democracy Boulevard, National Institutes of

Health, Bethesda, MC 20892–6600, (301)

594–8897.

(Catalogue of Federal Domestic Assistance

Program Nos. 93.847, Diabetes,

Endocrinology and Metabolic Research;

93.848, Digestive Diseases and Nutrition

Research; 93.849, Kidney Diseases, Urology

and Hematology Research, National Institutes

of Health, HHS)

Dated: May 18, 2001.

LaVerne Y. Stringfield,

Director, Office of Federal Advisory

Committee Policy.

[FR Doc. 01–13199 Filed 5–24–01; 8:45 am]

BILLING CODE 4140–01–M

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

National Institutes of Health

National Institute of Allergy and

Infectious Diseases; Notice of Closed

Meeting

Pursuant to section 10(d) of the

Federal Advisory Committee Act, as

amended (5 U.S.C. Appendix 2), notice

is hereby given of the following

meeting.

The meeting will be closed to the

public in accordance with the

provisions set forth in sections

552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,

as amended. The contract proposals and

the discussions could disclose

confidential trade secrets or commercial

property such as patentable material,

and personal information concerning

individuals associated with the contract

proposals, the disclosure of which

would constitute a clearly unwarranted

invasion of personal privacy.

Name of Committee: National Institute of

Allergy and Infectious Diseases Special

Emphasis Panel.

Date: June 13, 2001.

Time: 1:30 pm to 5 pm.

Agenda: To review and evaluate contract

proposals.

Place: 6700 B Rockledge Drive, Bethesda,

MD 20892 (Telephone Conference Call).

Contact Person: Anthony Macaluso,

Scientific Review Administrator, NIAID/

DEA, Scientific Review Program, Room 2217,

6700B Rockledge Drive, MSC–7616,

Bethesda, MD 20892–7616, 301–496–7465,

amacauso@niaid.nih.gov